Transplantation and Research Unit, Hospital Ramón y Cajal, Alcalá University, Carretera de Colmenar Km 9.100, 28034, Madrid, Spain.
Urology Department, Hospital Ramón y Cajal, Urology Surgical Research Group and Transplantation, IRYCIS, Alcalá University, Madrid, Spain.
Curr Urol Rep. 2020 Jan 18;21(1):4. doi: 10.1007/s11934-020-0957-6.
This review provides a critical literature overview of the risks and benefits of transplantectomy in patients with a failed allograft. Additionally, it offers a summary of related problems, primarily alloantibody sensitization in the event of nephrectomy and immunosuppression weaning.
Transplant nephrectomy has high morbidity and mortality rates. The morbidity of transplant nephrectomy (4.3 to 82%) is mostly due to hemorrhage or infection. Mortality rates range from 1.2 to 39%, and most are due to sepsis. Transvascular graft embolization has been described as a less invasive alternative technique for the management of symptomatic graft rejection, with minimal complications compared with transplantectomy. The number of patients with a failed allograft returning to dialysis is increasing. The role of allograft nephrectomy in the management of asymptomatic transplant failure is still controversial and up today continues to depend on the usual clinical practice of each institution. The less invasive transvascular embolization could have applicability in asymptomatic patients with the obvious lower morbidity and mortality rate.
本文批判性地综述了移植肾切除术后失败的患者接受移植肾切除的风险和获益。此外,本文还总结了相关问题,主要是在肾切除术后发生的同种异体抗体致敏和免疫抑制剂的逐渐停用。
移植肾切除术后的发病率和死亡率较高。移植肾切除术后的发病率(4.3%至 82%)主要是由于出血或感染所致。死亡率范围从 1.2%至 39%,大多数是由于败血症所致。与移植肾切除术相比,经血管移植栓塞术已被描述为一种治疗有症状移植物排斥反应的微创替代技术,其并发症较少。越来越多的移植肾失功患者需要返回透析治疗。在无症状移植肾失功的治疗中,移植肾切除的作用仍存在争议,目前仍然取决于每个机构的常规临床实践。对于无症状患者,经血管栓塞术具有更好的适用性,其发病率和死亡率明显较低。